Tyndall Capital Partners L P - Net Worth and Insider Trading
Tyndall Capital Partners L P Net Worth
The estimated net worth of Tyndall Capital Partners L P is at least $9,699 dollars as of 2024-11-13. Tyndall Capital Partners L P is the 10% Owner of Traws Pharma Inc and owns about 1,644 shares of Traws Pharma Inc (TRAW) stock worth over $9,699. Details can be seen in Tyndall Capital Partners L P's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tyndall Capital Partners L P has not made any transactions after 2019-09-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Tyndall Capital Partners L P
Tyndall Capital Partners L P Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tyndall Capital Partners L P owns 1 companies in total, including Traws Pharma Inc (TRAW) .
Click here to see the complete history of Tyndall Capital Partners L P’s form 4 insider trades.
Insider Ownership Summary of Tyndall Capital Partners L P
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TRAW | Traws Pharma Inc | 2019-09-24 | 10 percent owner |
Tyndall Capital Partners L P Latest Holdings Summary
Tyndall Capital Partners L P currently owns a total of 1 stock. Tyndall Capital Partners L P owns 1,644 shares of Traws Pharma Inc (TRAW) as of September 24, 2019, with a value of $9,699.
Latest Holdings of Tyndall Capital Partners L P
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TRAW | Traws Pharma Inc | 2019-09-24 | 1,644 | 5.90 | 9,699 |
Holding Weightings of Tyndall Capital Partners L P
Tyndall Capital Partners L P Form 4 Trading Tracker
According to the SEC Form 4 filings, Tyndall Capital Partners L P has made a total of 0 transactions in Traws Pharma Inc (TRAW) over the past 5 years. The most-recent trade in Traws Pharma Inc is the sale of 45 shares on September 24, 2019, which brought Tyndall Capital Partners L P around $19,873.
Insider Trading History of Tyndall Capital Partners L P
- 1
Tyndall Capital Partners L P Trading Performance
GuruFocus tracks the stock performance after each of Tyndall Capital Partners L P's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tyndall Capital Partners L P is -25.45%. GuruFocus also compares Tyndall Capital Partners L P's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tyndall Capital Partners L P within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Tyndall Capital Partners L P's insider trading performs compared to the benchmark.
Performance of Tyndall Capital Partners L P
Tyndall Capital Partners L P Ownership Network
Ownership Network List of Tyndall Capital Partners L P
Ownership Network Relation of Tyndall Capital Partners L P
Tyndall Capital Partners L P Owned Company Details
What does Traws Pharma Inc do?
Who are the key executives at Traws Pharma Inc?
Tyndall Capital Partners L P is the 10 percent owner of Traws Pharma Inc. Other key executives at Traws Pharma Inc include CHIEF MEDICAL OFFICER Victor M Moyo , VP Corp Dev & Gen Counsel Abraham N. Oler , and Chief Medical Officer Steven M Fruchtman .
Traws Pharma Inc (TRAW) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Traws Pharma Inc (TRAW) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Traws Pharma Inc (TRAW) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Traws Pharma Inc (TRAW)'s detailed insider trading history can be found in Insider Trading Tracker table.
Traws Pharma Inc Insider Transactions
Tyndall Capital Partners L P Mailing Address
Above is the net worth, insider trading, and ownership report for Tyndall Capital Partners L P. You might contact Tyndall Capital Partners L P via mailing address: 150 East 58th Street, 14th Floor, New York Ny 10155.